Hydrochlorothiazide; Olmesartan Medoxomil Patent Expiration
Hydrochlorothiazide; Olmesartan Medoxomil is Used for managing high blood pressure. It was first introduced by Cosette Pharmaceuticals Inc
Hydrochlorothiazide; Olmesartan Medoxomil Patents
Given below is the list of patents protecting Hydrochlorothiazide; Olmesartan Medoxomil, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Benicar Hct |
US6878703 (Pediatric) | Pharmaceutical composition |
May 19, 2022
(Expired) | Cosette |
| Benicar Hct | US6878703 | Pharmaceutical composition |
Nov 19, 2021
(Expired) | Cosette |
| Benicar Hct |
US5616599 (Pediatric) | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
Oct 25, 2016
(Expired) | Cosette |
| Benicar Hct | US5616599 | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
Apr 25, 2016
(Expired) | Cosette |
Hydrochlorothiazide; Olmesartan Medoxomil's Family Patents
Explore Our Curated Drug Screens
Hydrochlorothiazide; Olmesartan Medoxomil Generic API Manufacturers
Several generic applications have been filed for Hydrochlorothiazide; Olmesartan Medoxomil. The first generic version for Hydrochlorothiazide; Olmesartan Medoxomil was by Natco Pharma Usa Llc and was approved on Oct 26, 2016. And the latest generic version is by Alkem Laboratories Ltd and was approved on Jul 11, 2024.
Given below is the list of companies who have filed for Hydrochlorothiazide; Olmesartan Medoxomil generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 3 different strengths of generic version for Hydrochlorothiazide; Olmesartan Medoxomil. All of these versions come by the name OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG; 40MG | tablet | Prescription | ORAL | AB | Feb 7, 2019 |
| 12.5MG; 20MG | tablet | Prescription | ORAL | AB | Feb 7, 2019 |
| 12.5MG; 40MG | tablet | Prescription | ORAL | AB | Feb 7, 2019 |
2. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Hydrochlorothiazide; Olmesartan Medoxomil. All of these versions come by the name OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG; 40MG | tablet | Prescription | ORAL | AB | Apr 24, 2017 |
| 12.5MG; 20MG | tablet | Prescription | ORAL | AB | Apr 24, 2017 |
| 12.5MG; 40MG | tablet | Prescription | ORAL | AB | Apr 24, 2017 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
3. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 3 different strengths of generic version for Hydrochlorothiazide; Olmesartan Medoxomil. All of these versions come by the name HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG; 40MG | tablet | Prescription | ORAL | AB | Jul 11, 2024 |
| 12.5MG; 40MG | tablet | Prescription | ORAL | AB | Jul 11, 2024 |
| 12.5MG; 20MG | tablet | Prescription | ORAL | AB | Jul 11, 2024 |
4. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Hydrochlorothiazide; Olmesartan Medoxomil. All of these versions come by the name OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 12.5MG; 20MG | tablet | Prescription | ORAL | AB | Apr 24, 2017 |
| 12.5MG; 40MG | tablet | Prescription | ORAL | AB | Apr 24, 2017 |
| 25MG; 40MG | tablet | Prescription | ORAL | AB | Apr 24, 2017 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
| United States |
| |||||||||
5. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Hydrochlorothiazide; Olmesartan Medoxomil. All of these versions come by the name OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG; 40MG | tablet | Prescription | ORAL | AB | Jun 1, 2023 |
| 12.5MG; 20MG | tablet | Prescription | ORAL | AB | Jun 1, 2023 |
| 12.5MG; 40MG | tablet | Prescription | ORAL | AB | Jun 1, 2023 |
6. NATCO PHARMA USA
Natco Pharma Usa Llc has filed for 3 different strengths of generic version for Hydrochlorothiazide; Olmesartan Medoxomil. All of these versions come by the name OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Natco Pharma Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 12.5MG; 20MG | tablet | Discontinued | ORAL | N/A | Oct 26, 2016 |
| 12.5MG; 40MG | tablet | Discontinued | ORAL | N/A | Oct 26, 2016 |
| 25MG; 40MG | tablet | Discontinued | ORAL | N/A | Oct 26, 2016 |
7. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 3 different strengths of generic version for Hydrochlorothiazide; Olmesartan Medoxomil. All of these versions come by the name OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Prinston Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG; 40MG | tablet | Prescription | ORAL | AB | Apr 24, 2017 |
| 12.5MG; 40MG | tablet | Prescription | ORAL | AB | Apr 24, 2017 |
| 12.5MG; 20MG | tablet | Prescription | ORAL | AB | Apr 24, 2017 |
8. TEVA PHARMS USA
Teva Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Hydrochlorothiazide; Olmesartan Medoxomil. All of these versions come by the name OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 12.5MG; 20MG | tablet | Discontinued | ORAL | N/A | Apr 24, 2017 |
| 12.5MG; 40MG | tablet | Discontinued | ORAL | N/A | Apr 24, 2017 |
| 25MG; 40MG | tablet | Discontinued | ORAL | N/A | Apr 24, 2017 |
9. TORRENT
Torrent Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Hydrochlorothiazide; Olmesartan Medoxomil. All of these versions come by the name OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 12.5MG; 40MG | tablet | Discontinued | ORAL | N/A | May 3, 2017 |
| 25MG; 40MG | tablet | Discontinued | ORAL | N/A | May 3, 2017 |
| 12.5MG; 20MG | tablet | Discontinued | ORAL | N/A | May 3, 2017 |
Manufacturing Plant Locations New
Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||
| United States |
| |||||||||||
10. UMEDICA
Umedica Laboratories Private Ltd has filed for 3 different strengths of generic version for Hydrochlorothiazide; Olmesartan Medoxomil. All of these versions come by the name OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Umedica.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 12.5MG; 40MG | tablet | Prescription | ORAL | AB | Sep 17, 2019 |
| 12.5MG; 20MG | tablet | Prescription | ORAL | AB | Sep 17, 2019 |
| 25MG; 40MG | tablet | Prescription | ORAL | AB | Sep 17, 2019 |
Manufacturing Plant Locations New
Umedica's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Umedica as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
11. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Hydrochlorothiazide; Olmesartan Medoxomil. All of these versions come by the name OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 12.5MG; 40MG | tablet | Discontinued | ORAL | N/A | Feb 24, 2023 |
| 12.5MG; 20MG | tablet | Discontinued | ORAL | N/A | Feb 24, 2023 |
| 25MG; 40MG | tablet | Discontinued | ORAL | N/A | Feb 24, 2023 |